Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $26.57 billion. The enterprise value is $27.82 billion.
| Market Cap | 26.57B |
| Enterprise Value | 27.82B |
Important Dates
The next estimated earnings date is Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
Xylem has 237.69 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 237.69M |
| Shares Outstanding | 237.69M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 95.57% |
| Float | 237.06M |
Valuation Ratios
The trailing PE ratio is 27.80 and the forward PE ratio is 19.99. Xylem's PEG ratio is 1.67.
| PE Ratio | 27.80 |
| Forward PE | 19.99 |
| PS Ratio | 2.92 |
| Forward PS | 2.86 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 56.89 |
| P/FCF Ratio | 28.63 |
| P/OCF Ratio | 20.19 |
| PEG Ratio | 1.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.55, with an EV/FCF ratio of 29.98.
| EV / Earnings | 28.36 |
| EV / Sales | 3.06 |
| EV / EBITDA | 14.55 |
| EV / EBIT | 20.73 |
| EV / FCF | 29.98 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.46 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 1.00 |
| Debt / FCF | 2.22 |
| Interest Coverage | 53.68 |
Financial Efficiency
Return on equity (ROE) is 8.72% and return on invested capital (ROIC) is 8.56%.
| Return on Equity (ROE) | 8.72% |
| Return on Assets (ROA) | 5.01% |
| Return on Invested Capital (ROIC) | 8.56% |
| Return on Capital Employed (ROCE) | 9.45% |
| Weighted Average Cost of Capital (WACC) | 9.32% |
| Revenue Per Employee | $413,227 |
| Profits Per Employee | $44,591 |
| Employee Count | 22,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 5.54 |
Taxes
In the past 12 months, Xylem has paid $236.00 million in taxes.
| Income Tax | 236.00M |
| Effective Tax Rate | 19.54% |
Stock Price Statistics
The stock price has decreased by -10.20% in the last 52 weeks. The beta is 1.04, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -10.20% |
| 50-Day Moving Average | 114.34 |
| 200-Day Moving Average | 131.82 |
| Relative Strength Index (RSI) | 51.59 |
| Average Volume (20 Days) | 1,968,275 |
Short Selling Information
The latest short interest is 7.62 million, so 3.21% of the outstanding shares have been sold short.
| Short Interest | 7.62M |
| Short Previous Month | 6.09M |
| Short % of Shares Out | 3.21% |
| Short % of Float | 3.22% |
| Short Ratio (days to cover) | 3.74 |
Income Statement
In the last 12 months, Xylem had revenue of $9.09 billion and earned $981.00 million in profits. Earnings per share was $4.02.
| Revenue | 9.09B |
| Gross Profit | 3.51B |
| Operating Income | 1.34B |
| Pretax Income | 1.21B |
| Net Income | 981.00M |
| EBITDA | 1.91B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | $4.02 |
Balance Sheet
The company has $808.00 million in cash and $2.06 billion in debt, with a net cash position of -$1.25 billion or -$5.27 per share.
| Cash & Cash Equivalents | 808.00M |
| Total Debt | 2.06B |
| Net Cash | -1.25B |
| Net Cash Per Share | -$5.27 |
| Equity (Book Value) | 11.23B |
| Book Value Per Share | 45.89 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was $1.32 billion and capital expenditures -$388.00 million, giving a free cash flow of $928.00 million.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -388.00M |
| Depreciation & Amortization | 570.00M |
| Net Borrowing | -82.00M |
| Free Cash Flow | 928.00M |
| FCF Per Share | $3.90 |
Margins
Gross margin is 38.61%, with operating and profit margins of 14.76% and 10.79%.
| Gross Margin | 38.61% |
| Operating Margin | 14.76% |
| Pretax Margin | 13.29% |
| Profit Margin | 10.79% |
| EBITDA Margin | 21.03% |
| EBIT Margin | 14.76% |
| FCF Margin | 10.21% |
Dividends & Yields
This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 1.54%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 1.54% |
| Dividend Growth (YoY) | 9.21% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 41.29% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 1.47% |
| Earnings Yield | 3.69% |
| FCF Yield | 3.49% |
Analyst Forecast
The average price target for Xylem is $150.65, which is 34.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $150.65 |
| Price Target Difference | 34.79% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 3.91% |
| EPS Growth Forecast (3Y) | 10.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.61 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 7 |